Original article

Safety analysis on surgical treatment of elderly patients with primary retroperitoneal soft tissue sarcoma: a retrospective cohort study

Expand
  • 1. Department of General Surgery, Jinshan Hospital, Fudan University, Shanghai 201500, China
    2a. Department of Gene-ral Surgery, 2b. Department of Oncology, Zhongshan Hospital, Fudan University, Shanghai 200032, China

Received date: 2022-10-08

  Online published: 2023-01-30

Abstract

Objective: To analyze the risk factors for postoperative complications of the elderly patients with primary retroperitoneal sarcoma(RPS). Methods: A retrospective cohort study was performed for elderly patients with primary RPS treated by soft tissue sarcoma multidisciplinary team Zhongshan Hospital from July 2009 to December 2020. Logistic regression analysis was used to find risk factors for postoperative complications. Results: A total of 98 cases were enrolled including male 54 cases and female 44 cases with 26 cases (26.5%) of age 70 years or older. Five-year overall survival following surgery was 61.2% (60 cases with 95% confidence interval, 49.1-73.7). Seventy-eight cases (79.6%) had tumor burden greater than 10 cm, and 87 cases (88.8%) with single lesion. There were 35 cases (35.7%) with well-differentiated liposarcoma, 31 cases (31.6%) with dedifferentiated liposarcoma, and 15 cases (15.3%) with leiomyosarcoma. A total of 96 cases(98.0%) underwent radical resection and 54 cases (55.1%) had more than one organ resected. The postoperative complications were found 55 cases (56.1%) and severe complications 16 cases (16.3%). Four cases (4.1%) died postoperatively. It was shown by multivariate analysis that both tumor burden greater than 10 cm (OR=4.597, P=0.012) and more than one organ resected (OR=4.858, P=0.003) were independent risk factors for postoperative complications in elderly patients with RPS. Conclusions: Operative treatment remained the preferred type for elderly cases with primary RPS and the surgery should be completed in high-flow centers of RPS.

Cite this article

ZHUANG Aobo, TONG Hanxing, ZHANG Yong, LU Weiqi, ZHOU Yuhong, LÜ Chentao . Safety analysis on surgical treatment of elderly patients with primary retroperitoneal soft tissue sarcoma: a retrospective cohort study[J]. Journal of Surgery Concepts & Practice, 2022 , 27(06) : 534 -539 . DOI: 10.16139/j.1007-9610.2022.06.011

References

[1] Macneill AJ, Gronchi A, Miceli R, et al. Postoperative morbidity after radical resection of primary retroperitoneal sarcoma: a report from the Transatlantic RPS Working Group[J]. Ann Surg, 2018, 267(5):959-964.
[2] Siegel RL, Miller KD, Fuchs HE, et al. Cancer Statistics, 2021[J]. CA Cancer J Clin, 2021, 71(1):7-33.
[3] Swallow CJ, Strauss DC, Bonvalot S, et al. Management of primary retroperitoneal sarcoma (RPS) in the adult: an updated consensus approach from the Transatlantic Australasian RPS Working Group[J]. Ann Surg Oncol, 2021, 28(12):7873-7888.
[4] 童玉芬. 中国人口的最新动态与趋势 ——结合第七次全国人口普查数据的分析[J]. 中国劳动关系学院学报, 2021, 35(4):15-25.
[5] Zhuang A, Zhuang A, Wu Q, et al. Prognostic factor analysis and nomogram construction of primary retroperitoneal liposarcoma: a review of 10 years of treatment experience in a single Asian cohort of 211 cases[J]. Front Oncol, 2021, 11:777647.
[6] Bonvalot S, Miceli R, Berselli M, et al. Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high-volume centers is safe and is associated with improved local control[J]. Ann Surg Oncol, 2010, 17(6):1507-1514.
[7] Bonvalot S, Roland C, Raut C, et al. Histology-tailored multidisciplinary management of primary retroperitoneal sarcomas[J]. Eur J Surg Oncol, 2022, S0748-7983(22)00435-8.
[8] Gronchi A, Strauss DC, Miceli R, et al. Variability in patterns of recurrence after resection of primary retroperitoneal sarcoma(RPS): a report on 1007 patients from the multi-institutional collaborative RPS Working Group[J]. Ann Surg, 2016, 263(5):1002-1009.
[9] Judge SJ, Lata-Arias K, Yanagisawa M, et al. Morbidity, mortality and temporal trends in the surgical management of retroperitoneal sarcoma: an ACS-NSQIP follow up analysis[J]. J Surg Oncol, 2019, 120(4):753-760.
[10] Fiore M, Brunelli C, Miceli R, et al. A prospective observational study of multivisceral resection for retroperitoneal sarcoma: clinical and patient-reported outcomes 1 year after surgery[J]. Ann Surg Oncol, 2021, 28(7):3904-3916.
Outlines

/